dicycloverine ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
spasmolytics with a papaverine-like action 868 77-19-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • dicymine
  • dicycloverine hydrochloride
  • dicycloverine
  • dicyclomine
  • dicycloverin
  • dicyclomine hydrochloride
  • dicyclomine HCl
A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.
  • Molecular weight: 309.49
  • Formula: C19H35NO2
  • CLOGP: 6.14
  • LIPINSKI: 1
  • HAC: 3
  • HDO: 0
  • TPSA: 29.54
  • ALOGS: -4.98
  • ROTB: 8

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
80 mg O
80 mg P

ADMET properties:

PropertyValueReference
MRTD (Maximum Recommended Therapeutic Daily Dose) 4.30 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD

Approvals:

DateAgencyCompanyOrphan
May 11, 1950 FDA FOREST LABS INC

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Cholecystitis chronic 201.60 11.92 97 24476 9572 50570979
Biliary dyskinesia 107.28 11.92 42 24531 2508 50578043
Gallbladder disorder 84.63 11.92 68 24505 16674 50563877
Abdominal pain 79.81 11.92 274 24299 235954 50344597
Anxiety 78.36 11.92 226 24347 177380 50403171
Contraindicated product administered 56.85 11.92 4 24569 148954 50431597
Diarrhoea 48.32 11.92 466 24107 588010 49992541
Maternal exposure during pregnancy 47.19 11.92 10 24563 159768 50420783
Drug ineffective 45.22 11.92 225 24348 819108 49761443
Glossodynia 44.39 11.92 3 24570 115566 50464985
Synovitis 42.77 11.92 5 24568 123860 50456691
Depression 42.57 11.92 176 24397 165247 50415304
Abdominal pain upper 39.81 11.92 168 24405 159141 50421410
Drug intolerance 38.53 11.92 30 24543 219074 50361477
Colitis ulcerative 38.22 11.92 44 24529 16810 50563741
Gallbladder injury 36.43 11.92 16 24557 1278 50579273
Cholelithiasis 35.38 11.92 65 24508 37908 50542643
Treatment failure 34.29 11.92 12 24561 137625 50442926
Nausea 32.17 11.92 500 24073 704898 49875653
Joint swelling 29.45 11.92 46 24527 245240 50335311
Emotional distress 29.18 11.92 51 24522 28612 50551939
Injury 28.37 11.92 69 24504 48856 50531695
Rheumatoid arthritis 28.32 11.92 34 24539 202516 50378035
Pre-existing condition improved 28.00 11.92 25 24548 7072 50573479
Therapy partial responder 27.56 11.92 24 24549 6567 50573984
Biliary colic 27.35 11.92 18 24555 3241 50577310
Irritable bowel syndrome 27.15 11.92 70 24503 51371 50529180
Gallbladder hypofunction 26.95 11.92 10 24563 515 50580036
Constipation 26.21 11.92 167 24406 185541 50395010
General physical health deterioration 25.67 11.92 19 24554 142415 50438136
Migraine 25.04 11.92 87 24486 75193 50505358
Product dose omission issue 24.52 11.92 163 24410 183675 50396876
Flatulence 24.44 11.92 48 24525 29410 50551141
Abdominal distension 24.03 11.92 84 24489 72819 50507732
Poor peripheral circulation 22.83 11.92 16 24557 3192 50577359
Scleritis 22.75 11.92 16 24557 3211 50577340
Diverticulitis 21.63 11.92 49 24524 33133 50547418
Surgery 21.27 11.92 46 24527 30159 50550392
Small intestinal obstruction 20.98 11.92 32 24541 16036 50564515
Muscle spasms 20.96 11.92 118 24455 125435 50455116
Pain 20.73 11.92 395 24178 578508 50002043
Cholecystectomy 20.61 11.92 24 24549 9279 50571272
Thrombocytopenia 20.56 11.92 19 24554 127654 50452897
Wound 20.54 11.92 13 24560 105781 50474770
Arthropathy 20.52 11.92 28 24545 157878 50422673
Rhinalgia 20.49 11.92 10 24563 1016 50579535
Systemic lupus erythematosus 20.30 11.92 23 24550 140599 50439952
Therapeutic product effect decreased 19.91 11.92 22 24551 136028 50444523
Chest pain 19.61 11.92 150 24423 176732 50403819
Intestinal obstruction 19.52 11.92 41 24532 26342 50554209
Neutropenia 19.46 11.92 26 24547 147939 50432612
Vulvovaginal burning sensation 18.84 11.92 11 24562 1604 50578947
Palpitations 18.63 11.92 93 24480 94413 50486138
Impaired gastric emptying 18.50 11.92 22 24551 8696 50571855
Suicidal ideation 18.41 11.92 64 24509 55321 50525230
Clostridium difficile infection 18.21 11.92 39 24534 25400 50555151
Headache 17.90 11.92 345 24228 506190 50074361
Psychological trauma 17.76 11.92 9 24564 991 50579560
Abdominal pain lower 17.50 11.92 35 24538 21721 50558830
Weight decreased 17.42 11.92 174 24399 221071 50359480
Pancytopenia 16.76 11.92 10 24563 84020 50496531
Vulvovaginal pruritus 16.73 11.92 12 24561 2484 50578067
Drug interaction 16.70 11.92 46 24527 199575 50380976
Interstitial lung disease 16.37 11.92 3 24570 53173 50527378
Colitis 15.95 11.92 48 24525 38481 50542070
Hypoaesthesia 15.86 11.92 111 24462 127146 50453405
Neck pain 15.66 11.92 62 24511 57005 50523546
Intestinal mucosal hypertrophy 14.83 11.92 5 24568 194 50580357
Pancreatitis 14.82 11.92 50 24523 42564 50537987
C-reactive protein increased 14.59 11.92 7 24566 66467 50514084
Lower respiratory tract infection 14.37 11.92 15 24558 95186 50485365
Cholesterosis 14.24 11.92 6 24567 433 50580118
Back pain 14.06 11.92 166 24407 219864 50360687
Urinary tract infection 13.87 11.92 168 24405 223852 50356699
Tonsillitis fungal 13.66 11.92 3 24570 21 50580530
Hepatic enzyme increased 13.58 11.92 29 24544 137351 50443200
Vulvovaginal dryness 13.37 11.92 10 24563 2207 50578344
Haematochezia 13.18 11.92 46 24527 39836 50540715
Discharge 13.15 11.92 7 24566 854 50579697
Crying 13.14 11.92 30 24543 20386 50560165
Somnambulism 13.14 11.92 14 24559 4910 50575641
Bronchitis 13.06 11.92 91 24482 104068 50476483
Helicobacter infection 12.95 11.92 4 24569 49698 50530853
Diabetic neuropathy 12.89 11.92 12 24561 3579 50576972
Paranasal sinus discomfort 12.74 11.92 11 24562 2975 50577576
Hyponatraemia 12.53 11.92 17 24556 96122 50484429
Intervertebral disc degeneration 12.48 11.92 23 24550 13438 50567113
Anhedonia 12.48 11.92 19 24554 9505 50571046
Exposure during pregnancy 12.42 11.92 25 24548 120990 50459561
Infusion site erythema 12.28 11.92 18 24555 8709 50571842

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Irritable bowel syndrome 32.55 15.80 14 5321 2887 29566305
Abdominal pain 28.34 15.80 70 5265 135287 29433905
Diarrhoea 26.39 15.80 124 5211 332574 29236618
Alkalosis hypochloraemic 22.09 15.80 6 5329 305 29568887
Colitis ulcerative 21.33 15.80 18 5317 12751 29556441
Nausea 20.16 15.80 104 5231 289151 29280041
Apathy 17.66 15.80 12 5323 6159 29563033
Intestinal obstruction 16.77 15.80 19 5316 19258 29549934
Rectourethral fistula 16.28 15.80 3 5332 24 29569168
Suicidal ideation 15.90 15.80 25 5310 34691 29534501

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Cholecystitis chronic 199.93 12.64 86 22265 9201 64467180
Biliary dyskinesia 108.53 12.64 38 22313 2334 64474047
Gallbladder disorder 89.79 12.64 62 22289 16968 64459413
Abdominal pain 81.96 12.64 266 22085 312109 64164272
Anxiety 67.67 12.64 188 22163 202461 64273920
Diarrhoea 54.16 12.64 431 21920 722273 63754108
Pain 45.21 12.64 337 22014 553174 63923207
Colitis ulcerative 44.36 12.64 47 22304 22981 64453400
Abdominal pain upper 42.19 12.64 145 22206 174885 64301496
Irritable bowel syndrome 40.47 12.64 57 22294 37312 64439069
Gallbladder injury 39.85 12.64 15 22336 1133 64475248
Nausea 39.79 12.64 431 21920 785369 63691012
Product dose omission issue 32.00 12.64 143 22208 194604 64281777
Emotional distress 31.88 12.64 50 22301 35988 64440393
Injury 30.64 12.64 63 22288 55929 64420452
Neutropenia 30.59 12.64 23 22328 239601 64236780
Clostridium difficile infection 30.38 12.64 49 22302 36114 64440267
Cholelithiasis 29.51 12.64 55 22296 45451 64430930
Headache 27.90 12.64 293 22058 529174 63947207
Drug interaction 26.92 12.64 53 22298 362030 64114351
Diverticulitis 26.72 12.64 48 22303 38570 64437811
Migraine 25.85 12.64 63 22288 62614 64413767
Vulvovaginal burning sensation 25.63 12.64 11 22340 1168 64475213
Rhinalgia 25.55 12.64 11 22340 1177 64475204
Depression 24.60 12.64 127 22224 183164 64293217
General physical health deterioration 24.36 12.64 21 22330 204404 64271977
Flatulence 24.25 12.64 44 22307 35622 64440759
Cholecystectomy 24.23 12.64 21 22330 8011 64468370
Synovitis 24.05 12.64 3 22348 99087 64377294
Vision blurred 23.67 12.64 77 22274 90239 64386142
Gallbladder hypofunction 23.45 12.64 8 22343 454 64475927
Neck pain 22.40 12.64 59 22292 61474 64414907
Biliary colic 21.67 12.64 14 22337 3430 64472951
Drug intolerance 21.57 12.64 20 22331 187972 64288409
Interstitial lung disease 21.34 12.64 4 22347 97728 64378653
Drug ineffective 21.17 12.64 188 22163 840059 63636322
Abdominal pain lower 21.06 12.64 35 22316 26434 64449947
Surgery 20.72 12.64 36 22315 28177 64448204
Multiple organ dysfunction syndrome 20.41 12.64 5 22346 101408 64374973
Chest pain 19.92 12.64 145 22206 235835 64240546
Small intestinal obstruction 19.88 12.64 32 22319 23541 64452840
Abdominal distension 19.28 12.64 75 22276 95919 64380462
Thrombocytopenia 19.11 12.64 30 22321 223771 64252610
Parotitis 19.01 12.64 11 22340 2214 64474167
Psychological trauma 18.86 12.64 9 22342 1223 64475158
Pancreatitis 18.57 12.64 54 22297 59553 64416828
Hyperkalaemia 18.47 12.64 6 22345 101123 64375258
Constipation 18.26 12.64 139 22212 229198 64247183
Palpitations 18.11 12.64 78 22273 104410 64371971
Pancytopenia 17.96 12.64 14 22337 143295 64333086
Discharge 17.49 12.64 8 22343 988 64475393
Impaired gastric emptying 17.01 12.64 18 22333 8786 64467595
Intestinal obstruction 16.61 12.64 38 22313 36248 64440133
Crying 16.57 12.64 27 22324 20063 64456318
Cardiac failure 16.50 12.64 13 22338 132360 64344021
Back pain 16.35 12.64 145 22206 250026 64226355
Colitis 16.25 12.64 51 22300 58623 64417758
Alkalosis hypochloraemic 15.93 12.64 6 22345 454 64475927
Proctalgia 15.58 12.64 16 22335 7543 64468838
Paranasal sinus discomfort 15.49 12.64 11 22340 3144 64473237
Pre-existing condition improved 15.49 12.64 13 22338 4749 64471632
Vulvovaginal pruritus 15.26 12.64 9 22342 1877 64474504
Muscle spasms 15.11 12.64 92 22259 140931 64335450
Suicidal ideation 15.03 12.64 54 22297 66488 64409893
Urinary tract infection 15.01 12.64 134 22217 231462 64244919
Intestinal mucosal hypertrophy 14.93 12.64 5 22346 268 64476113
Presbyopia 14.68 12.64 6 22345 564 64475817
Tonsillitis fungal 14.67 12.64 3 22348 21 64476360
Bronchitis 13.65 12.64 74 22277 108669 64367712
Weight decreased 13.55 12.64 155 22196 285584 64190797
Glossodynia 13.39 12.64 3 22348 64693 64411688
Joint swelling 13.17 12.64 35 22316 215347 64261034
Abdominal hernia 12.97 12.64 12 22339 4983 64471398
Dizziness 12.91 12.64 215 22136 429948 64046433

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A03AA07 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
Synthetic anticholinergics, esters with tertiary amino group
FDA MoA N0000175370 Cholinergic Antagonists
FDA EPC N0000175574 Anticholinergic
CHEBI has role CHEBI:48876 muscarinic antagonists
CHEBI has role CHEBI:50370 parasympatholytics
CHEBI has role CHEBI:53784 antispasmodics
MeSH PA D018678 Cholinergic Agents
MeSH PA D018680 Cholinergic Antagonists
MeSH PA D018727 Muscarinic Antagonists
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D010276 Parasympatholytics
MeSH PA D018373 Peripheral Nervous System Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Irritable bowel syndrome indication 10743008 DOID:9778
Calculus in biliary tract off-label use 266474003
Brain damage contraindication 2470005
Tachyarrhythmia contraindication 6285003
Suicidal thoughts contraindication 6471006
Urinary tract obstruction contraindication 7163005 DOID:5200
Alcoholism contraindication 7200002
Hyperammonemia contraindication 9360008
Hepatic encephalopathy contraindication 13920009 DOID:13413
Severe chronic ulcerative colitis contraindication 14311001
Toxic megacolon contraindication 28536002 DOID:1770
Atony of colon contraindication 29479008
Hyperthyroidism contraindication 34486009 DOID:7998
Depressive disorder contraindication 35489007
Hypertensive disorder contraindication 38341003 DOID:10763
Complete trisomy 21 syndrome contraindication 41040004 DOID:14250
Achalasia of esophagus contraindication 45564002 DOID:9164
Chronic heart failure contraindication 48447003
Paralytic ileus contraindication 55525008 DOID:8442
Peptic reflux disease contraindication 57643001
Hepatic failure contraindication 59927004
Ulcerative colitis contraindication 64766004 DOID:8577
Poisoning by phenobarbital contraindication 64921004
Drug AND/OR toxin-induced diarrhea contraindication 65979008
Substance abuse contraindication 66214007
Hepatic coma contraindication 72836002 DOID:12550
Sleep apnea contraindication 73430006 DOID:0050847
Spastic paralysis contraindication 78403003
Disturbance of salivary secretion contraindication 78948009
Kidney disease contraindication 90708001 DOID:557
Myasthenia gravis contraindication 91637004 DOID:437
Gastrointestinal obstruction contraindication 126765001
Autonomic dysreflexia contraindication 129618003
Bleeding contraindication 131148009
Disease of liver contraindication 235856003 DOID:409
Bladder outflow obstruction contraindication 236645006
Benign prostatic hyperplasia contraindication 266569009
Dyspnea contraindication 267036007
Retention of urine contraindication 267064002
Anemia contraindication 271737000 DOID:2355
Pregnancy, function contraindication 289908002
Thrombocytopenic disorder contraindication 302215000 DOID:1588
Neutropenic disorder contraindication 303011007 DOID:1227
Angle-closure glaucoma contraindication 392291006 DOID:13550
Gastric ulcer contraindication 397825006 DOID:10808
Breastfeeding (mother) contraindication 413712001
Chronic lung disease contraindication 413839001
Disorder of coronary artery contraindication 414024009
Porphyria contraindication 418470004
Fever greater than 100.4 Fahrenheit contraindication 426000000




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 8.41 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Muscarinic acetylcholine receptor M3 GPCR ANTAGONIST Ki 9.03 DRUG MATRIX CHEMBL
Muscarinic acetylcholine receptor M1 GPCR ANTAGONIST Ki 9.08 DRUG MATRIX CHEMBL
5-hydroxytryptamine receptor 2A GPCR Ki 7.16 DRUG MATRIX
5-hydroxytryptamine receptor 2B GPCR Ki 6.08 DRUG MATRIX
5-hydroxytryptamine receptor 2C GPCR Ki 6.61 DRUG MATRIX
5-hydroxytryptamine receptor 6 GPCR Ki 5.85 DRUG MATRIX
D(3) dopamine receptor GPCR Ki 6.39 DRUG MATRIX
Histamine H2 receptor GPCR Ki 5.80 DRUG MATRIX
Muscarinic acetylcholine receptor M2 GPCR ANTAGONIST Ki 6.60 IUPHAR
Muscarinic acetylcholine receptor M4 GPCR Ki 9.39 DRUG MATRIX
Muscarinic acetylcholine receptor M5 GPCR Ki 8.77 DRUG MATRIX
Sigma non-opioid intracellular receptor 1 Membrane receptor Ki 8.69 DRUG MATRIX
Sodium channel alpha subunits; brain (Types I, II, III) Ion channel IC50 4.55 CHEMBL
Potassium voltage-gated channel subfamily H member 2 Ion channel Ki 4.77 DRUG MATRIX
Membrane-associated progesterone receptor component 1 Membrane receptor IC50 6.33 DRUG MATRIX
SMR1-alpha2 Unclassified Ki 6.54 DRUG MATRIX
Muscarinic acetylcholine receptor M2 GPCR Ki 7.33 CHEMBL
Muscarinic acetylcholine receptor M1 GPCR Ki 8.61 CHEMBL

External reference:

IDSource
4017870 VUID
N0000179550 NUI
D00717 KEGG_DRUG
67-92-5 SECONDARY_CAS_RN
152021 RXNORM
4017870 VANDF
4019716 VANDF
C0012125 UMLSCUI
CHEBI:4514 CHEBI
CHEMBL1123 ChEMBL_ID
CHEMBL1200479 ChEMBL_ID
DB00804 DRUGBANK_ID
355 IUPHAR_LIGAND_ID
3042 PUBCHEM_CID
158 MMSL
4587 MMSL
d00999 MMSL
001758 NDDF
004711 NDDF
372732007 SNOMEDCT_US
41493007 SNOMEDCT_US
71043005 SNOMEDCT_US
D004025 MESH_DESCRIPTOR_UI
619 INN_ID
4KV4X8IF6V UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0054-0622 SOLUTION 10 mg ORAL ANDA 24 sections
Dicyclomine HUMAN PRESCRIPTION DRUG LABEL 1 0143-1227 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0143-3126 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1610 CAPSULE 10 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1610 CAPSULE 10 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1620 TABLET 20 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1620 TABLET 20 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0440-7384 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0517-1980 INJECTION, SOLUTION 20 mg INTRAMUSCULAR ANDA 24 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0517-1980 INJECTION, SOLUTION 20 mg INTRAMUSCULAR ANDA 24 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0527-0586 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0527-1282 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0591-0794 CAPSULE 10 mg ORAL ANDA 25 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0591-0795 TABLET 20 mg ORAL ANDA 25 sections
dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0603-1161 SOLUTION 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0641-6173 INJECTION 10 mg INTRAMUSCULAR ANDA 25 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0641-6173 INJECTION 10 mg INTRAMUSCULAR ANDA 25 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6969 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6987 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6988 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 10135-520 CAPSULE 10 mg ORAL ANDA 25 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 10544-560 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine HUMAN PRESCRIPTION DRUG LABEL 1 10544-597 TABLET 20 mg ORAL ANDA 20 sections
Dicyclomine HCl HUMAN PRESCRIPTION DRUG LABEL 1 14789-010 INJECTION 10 mg INTRAMUSCULAR ANDA 25 sections
Dicyclomine HCl HUMAN PRESCRIPTION DRUG LABEL 1 14789-010 INJECTION 10 mg INTRAMUSCULAR ANDA 25 sections
dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 16590-077 CAPSULE 10 mg ORAL ANDA 11 sections
DICYCLOMINE HUMAN PRESCRIPTION DRUG LABEL 1 16590-324 TABLET 20 mg ORAL ANDA 8 sections
Dicyclomine HUMAN PRESCRIPTION DRUG LABEL 1 17478-015 INJECTION 20 mg INTRAMUSCULAR ANDA 25 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 17856-0623 SOLUTION 10 mg ORAL ANDA 24 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 17856-0623 SOLUTION 10 mg ORAL ANDA 24 sections